Add to ORKGWe report a case study of a term neonate presenting with oxygen desaturation without respiratory distress or acidosis, despite receiving 100% oxygen through a nasal cannula. Echocardiogram showed evidence of persistent pulmonary hypertension of the newborn (PPHN). She was successfully treated with inhaled nitric oxide (iNO) via nasal cannula without requiring mechanical ventilation. In a term neonate with idiopathic PPHN with adequate respiratory drive without any parenchymal lung disease, noninvasive methods of iNO delivery may treat the condition without the complications associated with mechanical ventilation
Persistent pulmonary hypertension of the newborn (PPHN) is characterized by elevated pulmonary vascu...
Parenchymal lung diseases are the main cause of persistent pulmonary hypertension of the newborn (PP...
Background. Persistent pulmonary hypertension of the newborn (PPHN) in patients with transposition o...
We report a case study of a term neonate presenting with oxygen desaturation without respiratory dis...
Abstract Background Inhaled nitric oxide (iNO) has been approved for the treatment of persistent pul...
Nitric oxide (NO) is a cellular signaling molecule and a powerful vasodilator. NO modulates basal pu...
Persistent pulmonary hypertension of the newborn (PPHN) is a clinical syndrome that is associated wi...
Respiratory failure in the premature newborn may be complicated by pulmonary hypertension (PAH) that...
Neonatal pulmonary hypertension refractory to high frequency ventilation (HFOV) and inhaled nitric o...
Background: Respiratory failure in term and near term infants is often associated with persistent pu...
Background Persistent pulmonary hypertension of the newborn remains a challenging problem in neona...
Persistent pulmonary hypertension of the newborn (PPHN) remains one of the most challenging situatio...
Background Neonates with pulmonary hypertension have been treated with inhaled nitric oxide because ...
Inhaled nitric oxide (NO) has been recently proposed as a new treatment in newborns and children wit...
AbstractObjectivesAlthough recognized for decades, little is known about the etiology, physiopatholo...
Persistent pulmonary hypertension of the newborn (PPHN) is characterized by elevated pulmonary vascu...
Parenchymal lung diseases are the main cause of persistent pulmonary hypertension of the newborn (PP...
Background. Persistent pulmonary hypertension of the newborn (PPHN) in patients with transposition o...
We report a case study of a term neonate presenting with oxygen desaturation without respiratory dis...
Abstract Background Inhaled nitric oxide (iNO) has been approved for the treatment of persistent pul...
Nitric oxide (NO) is a cellular signaling molecule and a powerful vasodilator. NO modulates basal pu...
Persistent pulmonary hypertension of the newborn (PPHN) is a clinical syndrome that is associated wi...
Respiratory failure in the premature newborn may be complicated by pulmonary hypertension (PAH) that...
Neonatal pulmonary hypertension refractory to high frequency ventilation (HFOV) and inhaled nitric o...
Background: Respiratory failure in term and near term infants is often associated with persistent pu...
Background Persistent pulmonary hypertension of the newborn remains a challenging problem in neona...
Persistent pulmonary hypertension of the newborn (PPHN) remains one of the most challenging situatio...
Background Neonates with pulmonary hypertension have been treated with inhaled nitric oxide because ...
Inhaled nitric oxide (NO) has been recently proposed as a new treatment in newborns and children wit...
AbstractObjectivesAlthough recognized for decades, little is known about the etiology, physiopatholo...
Persistent pulmonary hypertension of the newborn (PPHN) is characterized by elevated pulmonary vascu...
Parenchymal lung diseases are the main cause of persistent pulmonary hypertension of the newborn (PP...
Background. Persistent pulmonary hypertension of the newborn (PPHN) in patients with transposition o...